TAMEKA HAWKINS: Open Payments
NPI 1588200679 · WINDERMERE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 100 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,323 · 2025 $2,083
Food & beverage: $2,083
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $341 |
| AstraZeneca Pharmaceuticals LP | 15 | $335 |
| PFIZER INC. | 13 | $238 |
| Novo Nordisk Inc | 12 | $234 |
| Merck Sharp & Dohme LLC | 5 | $126 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Amgen Inc. | 5 | $96 |
| Exact Sciences Corporation | 4 | $91 |
| Lilly USA, LLC | 4 | $83 |
| Astellas Pharma US Inc | 4 | $80 |
Products named: QULIPTA, FARXIGA, NURTEC ODT, Wegovy, GARDASIL 9, Veozah, OTEZLA, MOUNJARO.
Industry payments across FL — which companies pay providers there.
